Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab-Treated non-small Cell Lung Cancer Patients.
Clin Pharmacol Ther. 2019 Feb;105(2):486-495. doi: 10.1002/cpt.1198. Epub 2018 Sep 4.
Clin Pharmacol Ther. 2019.
PMID: 30058723
Free PMC article.
Clinical Trial.
Tumor Time-Course Predicts Overall Survival in Non-Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow-Up Time.
Netterberg I, Bruno R, Chen YC, Winter H, Li CC, Jin JY, Friberg LE.
Netterberg I, et al.
CPT Pharmacometrics Syst Pharmacol. 2020 Feb;9(2):115-123. doi: 10.1002/psp4.12489. Epub 2020 Jan 28.
CPT Pharmacometrics Syst Pharmacol. 2020.
PMID: 31991070
Free PMC article.
Item in Clipboard
The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling.
Netterberg I, Karlsson MO, Nielsen EI, Quartino AL, Lindman H, Friberg LE.
Netterberg I, et al.
Br J Clin Pharmacol. 2018 Mar;84(3):490-500. doi: 10.1111/bcp.13477. Epub 2018 Jan 18.
Br J Clin Pharmacol. 2018.
PMID: 29178353
Free PMC article.
Item in Clipboard
Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring.
Netterberg I, Nielsen EI, Friberg LE, Karlsson MO.
Netterberg I, et al.
Cancer Chemother Pharmacol. 2017 Aug;80(2):343-353. doi: 10.1007/s00280-017-3366-x. Epub 2017 Jun 27.
Cancer Chemother Pharmacol. 2017.
PMID: 28656382
Free PMC article.
Item in Clipboard
Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework.
Netterberg I, Karlsson MO, Terstappen LWMM, Koopman M, Punt CJA, Friberg LE.
Netterberg I, et al.
Clin Cancer Res. 2020 Sep 15;26(18):4892-4900. doi: 10.1158/1078-0432.CCR-19-2570. Epub 2020 Jun 11.
Clin Cancer Res. 2020.
PMID: 32527941
Item in Clipboard
Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
Köck K, Ferslew BC, Netterberg I, Yang K, Urban TJ, Swaan PW, Stewart PW, Brouwer KL.
Köck K, et al. Among authors: netterberg i.
Drug Metab Dispos. 2014 Apr;42(4):665-74. doi: 10.1124/dmd.113.054304. Epub 2013 Oct 23.
Drug Metab Dispos. 2014.
PMID: 24154606
Free PMC article.
Item in Clipboard
Cite
Cite